Gastrointestinal polyposis syndromes

Current Problems in Surgery

Volumn 36, Issue 4, 1999, Pages 228-323

  Guillem, José G ^a,b   Smith, Andrew J ^a   Galle, Jorge Puig La ^a   Ruo, Leyo ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b Department of Obstetrics Gynecology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLON POLYPOSIS; COLORECTAL TUMOR; CONGENITAL TUMOR; FAMILIAL CANCER; GENETIC COUNSELING; GENETIC SCREENING; GENETICS; HUMAN; INTESTINE POLYP; INTESTINE TUMOR; REVIEW; RISK FACTOR;

ADENOMATOUS POLYPOSIS COLI; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; GENETIC COUNSELING; GENETIC SCREENING; HAMARTOMA SYNDROME, MULTIPLE; HUMANS; INTESTINAL NEOPLASMS; INTESTINAL POLYPS; NEOPLASTIC SYNDROMES, HEREDITARY; RISK FACTORS;

EID: 0033112221     PISSN: 00113840     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0011-3840(99)80013-6     Document Type: Article

References (355)

1. Phillips R, Spigelman AD, Thomson JPS. Familial adenomatous polyposis and other polyposis syndromes. Boston: Edward Arnold; 1994.
2. Bisgaard ML, Fenger K, Bulow S, et al. Familial adenomatous polyposis (FAP): frequency, penetrance, and mutation rate. Hum Mutât 1994;3:121-5
3. Campbell WJ, Spence RA, Parks TG. Familial adenomatous polyposis. Br J Surg 1994;81:1722-33.
4. Jarvinen HJ. Epidemiology of familial adenomatous polyposis in Finland: impact of family screening on the colorectal cancer rate and survival. Gut 1992;33:357-60.
5. Rustgi AK. Hereditary gastrointestinal polyposis and nonpolyposis syndromes. N Engl J Med 1994;331:1694-702.
6. Bulow S. Familial polyposis coli. Dan Med Bull 1987;34:1-15.
7. Rustin RB, Jagelman DG, McGannon E, et al. Spontaneous mutation in familial adenomatous polyposis. Dis Colon Rectum 1990;33:52-5.
8. Berk T, Cohen Z, McLeod RS, Stern HS. Management of mesenteric desmoid tumours in familial adenomatous polyposis. Can J Surg 1992;35:393-5.
9. Petersen GM. Genetic testing and counseling in familial adenomatous polyposis. Oncology (Hunting!) 1996; 10:89-98.
10. Bussey HJR. Familial polyposis coli: family studies, histopathology, differential diagnosis, and results of treatment. Baltimore: John Hopkins University Press; 1975.
11. Watne AL. The syndromes of intestinal polyposis. Curr Probl Surg 1987:24:269-340.
12. Bodmer WF, Bailey CJ, Bodmer J, et al. Localization of the gene for familial adenomatous polyposis on chromosome 5. Nature 1987;328:614-6.
13. Herrera L, Kakati S, Gibas L. et al. Gardner syndrome in a man with an interstitial deletion of 5q. Am J Med Genet 1986:25:473-6.
14. Kinzler KW, Nilbert MC, Su LK, et al. Identification of FAP locus genes from chromosome 5q21. Science 1991:253:661-5.
15. Groden J. Thliveris A. Samowitz W, et al. Identification and characterization of the familial adenomatous polyposis coli gene. Cell 1991;66:589-600.
16. Joslyn G. Carlson M, Thliveris A, et al. Identification of deletion mutations and three new genes at the familial polyposis locus. Cell 1991:66:601-13.
17. Nishisho I. Nakamura Y. Miyoshi Y. et al. Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients. Science 1991:253:665-9.
18. Su LK, Johnson KA, Smith KJ. et al. Association between wild type and mutant APC gene products. Cancer Res 1993:53:2728-31.
19. Laken SJ, Petersen GM, Gruber SB, et al. Familial colorectal cancer in Ashkenazim due to a hypermutable tract in APC. Nat Genet 1997:17:79-83.
20. Miyoshi Y, Nagase H. Ando H. et al. Somatic mutations of the APC gene in colorectal tumors: mutation cluster region in the APC gene. Hum Mol Genet 1992:1:229-33.
21. Gumbiner BM. Carcinogenesis: a balance between beta-catenin and APC. Curr Biol 1997;7:R443-6.
22. Kinzler KW, Vogelstein B. Lessons from hereditary colorectal cancer. Cell 1996:87:159-70.
23. Sparks AB, Morin PJ. Vogelstein B, Kinzler KW. Mutational analysis of the APC/beta-catenin/Tcf pathway in colorectal cancer. Cancer Res 1998:58:1130-4.
24. Smith KJ. Johnson KA, Bryan TM, et al. The APC gene product in normal and tumor cells. Proc Natl Acad Sei U S A 1993:90:2846-50.
25. Smith KJ. Levy DB, Maupin P. et al. Wild-type but not mutant APC associates with the microtubule cytoskeleton. Cancer Res 1994;54:3672-5.
26. Joslyn G, Richardson DS, White R, Alber T. Dimer formation by an N-terminal coiled coil in the APC protein. Proc Natl Acad Sei USA 1993:90:11109-13.
27. Su LK. Vogelstein B, Kinzler KW. Association of the APC tumor suppressor protein with catenins. Science 1993:262:1734-7.
28. Rubinfeld B, Souza B. Albert I. et al. The APC protein and E-cadherin form similar but independent complexes with alpha-catenin. beta-catenin, and plakoglobin. J Biol Chem 1995:270:5549-55.
29. Munemitsu S, Souza B. Muller O, et al. The APC gene product associates with microtubules in vivo and promotes their assembly in vitro. Cancer Res 1994:54:3676-81.
30. Pennisi E. How a growth control path takes a wrong turn to cancer (published erratum appears in Science 1998 Sep 18:281:1809). Science 1998:281:1438-9, 1441.
31. Scott RJ, van der Luijt R. Spycher M. et al. Novel germline APC gene mutation in a large familial adenomatous polyposis kindred displaying variable phenotypes. Gut 1995:36:731-6.
32. Friedl W, Meuschel S, Caspari R, et al. Attenuated familial adenomaious polyposis due to a mutation in the 3' part of the APC gene: a clue for understanding the function of the APC protein. Hum Genet 1996:97:579-84.
33. van der Luijt RB, Meera Khan P, Vasen HF, et al. Germline mutation; in thé 3' part of APC exon 15 do not result in truncated proteins and are associated with attenuated adenomatous polyposis coli. Hum Genet 1996:98:727-34.
34. Lynch HT, Smyrk T, McGinn T, et al. Attenuated familial adenomaious polyposis (AFAP): a phenotypically and genotypically distinctive variant of FAP. Cancer 1995:76:2427-33.
35. Spirio L, Olschwang S, Groden J, et al. Alleles of the APC gene: an attenuated form of familial polyposis. Cell 1993:75:951-7.
36. Caspari R, Olschwang S, Friedl W, et al. Familial adenomatous polyposis: desmoid tumours and lack of ophthalmic lesions (CHRPE) associated with APC mutations beyond codon 1444. Hum Mol Genet 1995:4:337-40.
37. Paul P. Letteboer T, Gelbert L, et al. Identical APC exon 15 mutations result in a variable phenotype in familial adenomatous polyposis. Hum Mol Genêt 1993:2:925-31.
38. Gayther SA, Wells D, SenGupta SB, et al. Regionally clustered APC mutations are associated with a severe phenotype and occur at a high frequency in new mutation cases of adenomatous polyposis coli. Hum Mol Genet 1994;3:53-6.
39. Nugent KP, Phillips RK, Hodgson SV, et al. Phenotypic expression in familial adenomatous polyposis: partial prediction by mutation analysis. Gut 1994:35:1622-3.
40. Nagase H, Nakamura Y. Mutations of the APC (adenomatous polyposis coli) gene. Hum Mutât 1993:2:425-34.
41. Wu JS. Paul P, McGannon EA, Church JM. APC genotype, polyp number, and surgical options in familial adenomatous polyposis. Ann Surg 1998:227:57-62.
42. Olschwang S. Tiret A, Laurent-Puig P, et al. Restriction of ocular fundus lesions to a specific subgroup of APC mutations in adenomatous polyposis coli patients. Cell 1993:75:959-68.
43. Wallis YL, Macdonald F, Hulten M, et al. Genotypephenotype correlation between position of constitutional APC gene mutation and CHRPE expression in familial adenomatous polyposis. Hum Genet 1994:94:543-8.
44. Fodde R, Khan PM. Genotype-phenotype correlations at the adenomatous polyposis coli (APC) gene. Crit Rev Oncol 1995:6:291-303.
45. Davies DR, Armstrong JG, Thakker N, et al. Severe Gardner syndrome in families with mutations restricted to a specific region of the APC gene. Am J Hum Genet 1995:57:1151-8.
46. Giardiello FM, Krush AJ, Petersen GM, et al. Phenotypic variability of familial adenomatous polyposis in 11 unrelated families with identical APC gene mutation. Gastroenterology 1994; 106:1542-7.
47. MacPhee M, Chepenik KP, Liddell RA, et al. The secretory phosphol pase A2 gene is a candidate for the Moral locus, a major modifier of ApcMin-indtced intestinal neoplasia. Cell 1995:81:957-66.
48. Laird PW, Jackson-Grusby L, Fazeli A, et al. Suppression of intestinal neoplasia by DNA hypomethylation. Cell 1995;81:197-205.
49. Dobbie Z, Heinimann K, Bishop DT, et al. Identification ot a modifier gene locus on chromosome lp35-36 in familial adenomatous polyposis. Hum Genet 1997;99:653-7.
50. Dietrich WF, Lander ES, Smith JS, et al. Genetic identification of Mom-1, a major modifier locus affecting Min- induced intestinal neoplasia in the mouse. Cell 1993:75:631-9.
51. Powell SM, Zilz N, Beazer-Barclay Y, et al. APC mutations occur early during eolorectal tumorigenesis. Nature 1992:359:235-7.
52. Levy DB, Smith KJ, Beazer-Barclay Y, et al. Inactivation of both APC alleles in human and mouse tumors. Cancer Res 1994:54:5953-8.
53. Jagelman DG. Extra-colonie manifestations of familial adenomatous polyposis. Oncology (Hunting!) 1991:5:23-36.
54. Kurtz RC. Sternberg SS, Miller HH, Decosse JJ. Upper gastrointestinal neoplasia in familial polyposis. Dig Dis Sei 1987:32:459-65.
55. Church JM, McGannon E, Hull-Boiner S, et al. Gastroduodena! polyps in patients with familial adenomatous polyposis. Dis Colon Rectum 1992:35:1170-3.
56. Hamilton SR, Liu B, Parsons RE, et al. The molecular basis of Turcot's syndrome. N Engl J Med 1995:332:839-47.
57. Dunlop MG, Farrington SM, Bubb VJ, et al. Extracolonic features of familial adenomatous polyposis in patients with sporadic colorectal cancer. Br J Cancer 1996:74:1789-95.
58. Nugent KP, Spigelman AD. Phillips RK. Risk of extracolonic cancer in familial adenomatous polyposis. Br J Surg 1996:83:1121-2.
59. Stigt JA, Vasen HF, van der Linde K, van Vliet AC. Thyroid carcinoma as first manifestation of familial adenomatous polyposis. Neth J Med 1996:49:116-8.
60. Clark SK. Pack K, Pritchard J, Hodgson SV. Familial adenomatous polyposis presenting with childhood desmoid tumors [letter]. Lancet 1997:349:471-2.
61. Howe JR. Guillem JG. The genetics of colorectal cancer. Surg Clin North Am 1997:77:175-95.
62. Bapat BV, Parker JA, Berk T, et al. Combined use of molecular and biomarkers for presymptomatic carrier risk assessment in familial adenomatous polyposis: implications for screening guidelines. Dis Colon Rectum 1994:37:165-71.
63. Shields JA, Shields CL, Shah PG, et al. Lack of association among typical congenital hypertrophy of the retinal pigment epithelium, adenomatous polyposis, and Gardner syndrome. Ophthalmology 1992:99:1709-13.
64. Tiret A, Taiel-Sartral M, Tiret E, Laroche L. Diagnostic value of fundus examination in familial adenomatous polyposis. Br J Ophthalmol 1997:81:755-8.
65. Utsunomiya J, Nakamura T. The occult osteomatous changes in the mandible in patients with familial polyposis coli. Br J Surg 1975:62:45-51.
66. Iwama T, Mishima Y. Mortality in young first-degree relatives of patients with familial adenomatous polyposis. Cancer 1994:73:2065-8.
67. Giardiello FM. Petersen GM. Brensinger JD, et al. Hepatoblastoma and APC gene mutation in familial adenomatous polyposis. Gut 1996:39:867-9.
68. Arvanitis ML, Jagelman DG, Fazio VW. et al. Mortality in patients with familial adenomatous polyposis. Dis Colon Rectum 1990:33:639-42.
69. Giardiello FM, Offerhaus GJ, Lee DH, et al. Increased risk of thyroid and pancreatic carcinoma in familial adenomatous polyposis. Gut 1993:34:1394-6.
70. Cetta F, Toti P, Petracci M, et al. Thyroid carcinoma associated with familial adenomatous polyposis. Histopathology 1997;31:231-6.
71. Varesco L, Gismondi V, James R, et al. Identification of APC gene mutations in Italian adenomatous polyposis coli patients by PCR-SSCP analysis. Am J Hum Genet 1993:52:280-5.
72. Bulow C, Bulow S. Is screening for thyroid carcinoma indicated in familial adenomatous polyposis? The Leeds Castle Polyposis Group. Int J C'olorectal Dis 1997 ;12:240-2.
73. Rhodes M, Chapman PD, Bum J, Gunn A. Role of a regional register for familial adenomatous polyposis: experience in the northern region. Br J Surg 1991 ;78:451-2.
74. Vasen HF, Griffioen G, Offerhaus GJ, et al. The value of screening and central registration of families with familial adenomatous polyposis: a study of 82 families in The Netherlands. Dis Colon Rectum 1990;33:227-30.
75. Nugent KP, Spigelman AD, Phillips RK. Life expectancy after colectomy and ileorectal anastomosis for familial adenomatous polyposis. Dis Colon Rectum 1993;36:1059-62.
76. Powell SM, Petersen GM, Krush AJ, et al. Molecular diagnosis of familial adenomatous polyposis. N Engl J Med 1993;329:1982-7.
77. Dunlop MG, Wyllie AH, Steel CM, et al. Linked DNA markers for presymptomatic diagnosis of familial adenomatous polyposis. Lancet 1991;337:313-6.
78. Petersen GM, Slack J, Nakamura Y. Screening guidelines and premorbid diagnosis of familial adenomatous polyposis using linkage. Gastroenterology 1991 ;100: 1658-64.
79. Bapat B, Mitri A, Greenberg CR. Improved predictive carrier testirg for familial adenomatous polyposis using DNA from a single archival specimen and polymorphic markers with multiple alleles. Hum Pathol 1993;24:1376-9.
80. Cama A, Guanti G, Mareni C, et al. Recommendations for the molecular diagnosis of familial adenomatous polyposis. Tumori 1997;83:795-9.
81. Miyaki M, Konishi M, Kikuchi-Yanoshita R, et al. Characteristics of somatic mutation of the adenomatous polyposis coli gene in colorectal tumors. Cancer Res 1994;54:3011-20.
82. Bapat B, Berk T, Mitri A, et al. Characterization of two novel adenomatous polyposis coli (APC) gene mutations in patients with familial adenomatous polyposis (FAP). Hum Mutât 1994;4:253-6.
83. Sheffield VC, Beck JS, Kwitek AE, et al. The sensitivity of single-strand conformation polymorphism analysis for the detection of single base substitutions. Genomics 1993;16:325-32.
84. Giardiello FM, Brensinger JD, Petersen GM, et al. The use and interpretation of commercial APC gene testing for familial adenomatous polyposis. N Engl J Med 1997:336:823-7.
85. Statement of the American Society of Clinical Oncology: genetic testing for cancer susceptibility, Adopted on February 20, 1996. J Clin Oncol 1996;14:1730-40.
86. Wertz DC, Fanos JH, Reilly PR. Genetic testing for children and adolescents. Who decides? JAMA 1994;272:875-81.
87. Petersen GM, Boyd PA. Gene tests and counseling for colorecta cancer risk: lessons from familial polyposis. J Natl Cancer Inst Monogr 1995;17:67-71.
88. Lapham EV, Kozma C, Weiss JO. Genetic discrimination: perspectives of consumers. Science 1996:274:621-4.
89. Masood E. Gene tests: who benefits from risk? Nature 1996;379:389, 391-2.
90. Phillips RK, Spigelman AD. Can we safely delay or avoid prophylactic colectomy in familial adenomatous polyposis? Br J Surg 1996;83:769-70.
91. Giardiello FM. NSAID-induced polyp regression in familial adenomatous polyposis patients. Gastroenterol Clin North Am 1996;25:349-62.
92. Sheng H, Shao J, Morrow JD, et al. Modulation of apoptosis and Bcl-2 expression by prostaglandin E2 in human colon cancer cells. Cancer Res 1998;58:362-6.
93. Chan TA, Morin PJ, Vogelstein B, Kinzler KW. Mechanisms underlying nonsteroidal antiinflammatory drug-mediated apoptosis. Proc Natl Acad Sei U S A 1998;95:681-6.
94. Piazza GA, Alberts DS, Hixson LJ, et al. Sulindac sulfone inhibits azoxymethaneinduced colon carcinogenesis in rats without reducing prostaglandin levels. Cancer Res 1997 ;57:2909-15.
95. Elder DJ, Paraskeva C. COX-2 inhibitors for colorectal cancer. Nat Med 1998;4:392-3.
96. Nugent KP, Farmer KC, Spigelman AD, et al. Randomized controlled trial of the effect of sulindac on duodenal and rectal polyposis and cell proliferation in patients with familial adenomatous polyposis. Br J Surg 1993;80:1618-9.
97. Labayle D, Fischer D, Vielh P, et al. Sulindac causes regression of rectal polyps in familial adenomatous polyposis. Gastroenterology 1991; 101:635-9.
98. Giardiello FM, Hamilton SR, Krush AJ, et al. Treatment of colonie and rectal adenomas with sulindac in familial adenomatous polyposis. N Engl J Med 1993;328:1313-6.
99. Winde G, Schmid KW, Brandt B, et al. Clinical and genomic influence of sulindac on rectal mucosa in familial adenomatous polyposis. Dis Colon Rectum 1997 ;40:1156-69.
100. Lynch HT, Thorson AG, Smyrk T. Rectal cancer after prolonged sulindac chemoprevention: a case report. Cancer 1995;75:936-8.
101. Nugent KP, Phillips RK. Rectal cancer risk in older patients with familial adenomatous polyposis and an ileorectal anastomosis: a cause for concern. Br J Surg 1992;79:1204-6.
102. Mills SJ, Chapman PD, Burn J, Gunn A. Endoscopie screening and surgery for familial adenomatous polyposis: dangerous delays. Br J Surg 1997;84:74-7.
103. Jarvinen HJ. Time and type of prophylactic surgery for familial adenomatosis coli. Ann Surg 1985;202:93-7.
104. Setti-Carraro P, Nicholls RJ. Choice of prophylactic surgery for the large bowel component of familial adenomatous polyposis. Br J Surg 1996;83:885-92.
105. McLeod RS, Lavery IC, Leatherman JR, et al. Patient evaluation of the conventional ileostomy. Dis Colon Rectum 1985;28:152-4.
106. Kock NG. Intra-abdominal "reservoir" in patients with permanent ileostomy: preliminary observations on a procedure resulting in fecal "continence" in five ileostomy patients. Arch Surg 1969;99:223-31.
107. Dozois RR, Kelly KA, Beart RW Jr, Beahrs OH. Improved results with continent ileostomy. Ann Surg 1980;192:319-24.
108. Bussey HJ, Eyers AA, Ritchie SM, Thomson JP. The rectum in adenomatous polyposis: the St. Mark's policy. Br J Surg 1985;72(suppl):S29-31.
109. Moertel CG, Hill JR, Adson MA. Surgical management of multiple polyposis: the problem of cancer in the retained bowel segment. Arch Surg 1970;100:521 -6.
110. Iwama T, Mishima Y. Factors affecting the risk of rectal cancer following rectumpreserving surgery in patients with familial adenomatous polyposis. Dis Colon Rectum 1994;37:1024-6.
111. Bulow S. The risk of developing rectal cancer after colectomy and ileorectal anastomosis in Danish patients with polyposis coli. Dis Colon Rectum l<>84;27:726-9.
112. Bertario L, Presciuttini S, Sala P, et al. Causes of death and postsurgical survival in familial adenomatous polyposis: results from the Italian Registry. Italian Registry of Familial Polyposis Writing Committee. Semin Surg Oncol 1994; 10:225-34.
113. De Cosse JJ, Bulow S, Neale K, et al. Rectal cancer risk in patients treated for familial adenomatous polyposis: the Leeds Castle Polyposis Group. Br J Surg 1992;79:1372-5.
114. Sagar PM, Pemberton JH. Operations for familial adenomatous polyposis. Surg Oncol Clin N Am 1996;5:675-88.
115. O'Connell PR, Pemberton JH, Weiland LH, et al. Does rectal mucosa regenerate after ileoanal anastomosis? Dis Colon Rectum 1987;30:l-5.
116. Heppell J, Weiland LH, Perrault J, et al. Fate of the rectal mucosa after rectal mucosectomy and ileoanal anastomosis. Dis Colon Rectum 1983;26:768-77l.
117. Slors JF, Ponson AE, Taat CW, Bosnia A. Risk of residual rectal mucosa after proctocolectomy and ileal pouch-anal reconstruction with the double-stapling technique: postoperative endoscopie follow-up study. Dis Colon Rectum 1995;33:207-10.
118. Malassagne B, Penna C, Parc R. Adenomatous polyps in the anal transitional zone after ileal pouch-anal anastomosis for familial adenomatous polyposis: treatment by transanal mucosectomy and ileal pouch advancement. Br J Surg ) 1995 ;82:1634.
119. Stern H, Walfisch S, Müllen B, et al. Cancer in an ileoanal reservoir: a new late complication? Gut 1990;31:473-5.
120. Hoehner JC, Metcalf AM. Development of invasive adenocarcinoma following colectomy with ileoanal anastomosis for familial polyposis coli: report of a case. Dis Colon Rectum 1994; 37:824-8.
121. von Herbay A, Stern J, Herfarth C. Pouch-anal cancer after restorative proctocolectomy for familial adenomatous polyposis. Am J Surg Pathol 1996;26:995-9.
122. Myrhoj T, Bulow S, Mogensen AM. Multiple adenomas in terminal ileum 25 years after restorative proctocolectomy for familial adenomatous polyposis: report of a case. Dis Colon Rectum 1989;32:618-20.
123. Church JM, Oakley JR, Wu JS. Pouch polyposis after ileal pouch-anal anastomosis for familial adenomatous polyposis: report of a case. Dis Colon Rectum 1996;39:584-6.
124. Stryker SJ, Carney JA, Dozois RR. Multiple adenomatous polyps arising in a continent reservoir ileostomy. Int J Colorectal Dis 1987;2:43-5.
125. van Duijvendijk P, Vasen HFA, Bertario L, et al. The cumulative risk of developing polyps or malignancy at the ileal-pouch-anal-anastomosis in patients wiili familial adenomatous polyposis (FAP). J Gastrointest Surg. In press.
126. Tytgat GN, Gopinath N. Recurrent polyps in the ileo-anal pouch or rectum in familial adenomatous polyposis. Eur J Cancer 1995;31A:1154-9.
127. Mowschenson PM, Critchlow JF. Outcome of early surgical complications following ileoanal pouch operation without diverting ileostomy. Am J Surg 1995;169:143-6.
128. Gorfine SR, Gelernt IM, Bauer JJ, et al. Restorative proctocolectomy without diverting ileostomy. Dis Colon Rectum 1995;38:188-94.
129. Tjandra JJ, Fazio VW, Milsom JW, et al. Omission of temporary diversion in restorative proctocolectomy: Is it safe? Dis Colon Rectum 1993:36:1007-14.
130. Fazio VW, Ziv Y, Church JM, et al. Heal pouch-anal anastomoses complications and function in 1005 patients. Ann Surg 1995:222:120-7.
131. Madden MV, Neale KF, Nicholls RJ, et al. Comparison of morbidity and function after colectomy with ileorectal anastomosis or restorative proctocolectomy for familial adenomatous polyposis. Br J Surg 1991:78:789-92.
132. Ambroze WL Jr, Dozois RR, Pemberton JH, et al. Familial adenomatous polyposis: results following ileal pouch-anal anastomosis and ileorectostomy. Dis Colon Rectum 1992;35:12-5.
133. Debinski HS, Love S, Spigelman AD, Phillips RK. Colorectal polyp counts and cancer risk in familial adenomatous polyposis. Gastroenterology 1996;! 10:1028-30.
134. Vasen HF, van der Luijt RB, Slors JF, et al. Molecular genetic tests as a guide to surgical management of familial adenomatous polyposis. Lancet 1996:348:433-5.
135. Wiltz O. Hashmi HF, Schoetz DJ Jr, et al. Carcinoma and the ileal pouch-anal anastomosis. Dis Colon Rectum 1991:34:805-9.
136. Church JM. Desmoid tumors in patients with familial adenomatous polyposis. Seminars in Colon and Rectal Surgery 1995:6:29-32.
137. Penna C, Tiret E, Parc R, et al. Operation and abdominal desmoid tumors in familial adenomatous polyposis. Surg Gynecol Obstet 1993:177:263-8.
138. Debinski HS, Spigelman AD, Hatfield A, et al. Upper intestinal surveillance in familial adenomatous polyposis. Fur J Cancer 1995:31 A: 1149-53.
139. Jarvinen HJ, Sipponen P. Gastroduodenal polyps in familial adenomatous and juvenile polyposis. Endoscopy 1986:18:230-4.
140. Spigelman AD, Talbot 1C, Penna C. et al. Evidence for adenoma-carcinoma sequence in the duodenum of patients with familial adenomatous polyposis: the Leeds Castle Polyposis Group (Upper Gastrointestinal Committee). J Clin Pathol 1994:47:709-10.
141. Spigelman AD, Williams CB, Talbot IC, et al. Upper gastrointestinal cancer in patients with familial adenomatous polyposis. Lancet 1989:2:783-5.
142. van Stolk R, Sivak MV Jr, Petrini JL, et al. Endoscopie management of upper gastrointestinal polyps and periampullary lesions in familial adenomatous polyposis and Gardner's syndrome. Endoscopy 1987; 19(suppl): 19-22.
143. Sanabria JR, Croxford R, Berk TC, et al. Familial segregation in the occurrence and severity of periampullary neoplasms in familial adenomatous polyposis. Am J Surg 1996:171:136-41.
144. Scales DK, Spigelman AD, Nugent KP, et al. DNA adducts, detected by 32P-postlabelling, in DNA treated in vitro with bile from patients with familial adenomatous polyposis and from unaffected controls. Carcinogenesis 1993:14:1107-10.
145. Vasen HF, Bulow S, Myrhoj T, et al. Decision analysis in the management of duodenal adenomatosis in familial adenomatous polyposis. Gut 1997;40:716-9.
146. DuBois RN, Giardiello FM, Smalley WE. Nonsteroidal anti-inflammatory drugs, eicosanoids, and colorectal cancer prevention. Gastroenterol Clin North Am 1996:25:773-91.
147. Parker AL, Kadakia SC, Maccini DM, et al. Disappearance of duodenal polyps in Gardner's syndrome with sulindac therapy. Am J Gastroenterol 1993:88:93-4.
148. Mlkvy P, Messmann H, Debinski H, et al. Photodynamic therapy for polyps in familial adenomatous polyposis: a pilot study. Eur J Cancer 1995;31A: 1160-5.
149. Griffîoen G, Bus PJ, Vasen HF, et al. Extracolonic manifestations ol' familial adenomatous polyposis: desmoid tumours, and upper gastrointestinal adenomas and carcinomas. Scand J Gastroenterol Suppl 1998:225:85-91.
150. Chung RS, Church JM, vanStolk R. Pancreas-sparing duodenectomy: indications, surgical technique, and results. Surgery 1995;! 17:254-9.
151. Tio TL, Mulder CJ, Eggink WF. Endosonography in staging early carcinoma of the ampulla of vater. Gastroenterology 1992:102:1392-5.
152. Penna C, Phillips RK, Tiret E, Spigelman AD. Surgical polypectomy of duodenal adenomas in familial adenomatous polyposis: experience of two European centres. BrJSurg 1993 ;80:1027-9.
153. Penna C, Bataille N, Balladur P, et al. Surgical treatment of severe duodenal polyposis in familial adenomatous polyposis. Br J Surg 1998:85:665-8.
154. Gurbuz AK, Giardiello FM, Petersen GM, et al. Desmoid tumours in familial adenomatous polyposis. Gut 1994:35:377-81.
155. Jones IT, Jagelman DG, Fazio VW, et al. Desmoid tumors in familial polyposis coli. Ann Surg 1986:204:94-7.
156. Rodriguez-Bigas MA, Mahoney MC, Karakousis CP, Petrelli NJ. Desmoid tumors in patients with familial adenomatous polyposis. Cancer 1994:74:1270-4.
157. Clark SK, Phillips RK. Desmoid tumors in familial adenomatous polyposis. Br J Surg 1996;83(: 1494-504.
158. Reitamo JJ, Hayry P, Nykyri E, Saxen E. The desmoid tumor. I. Incidence, sex-, age- and anatomical distribution in the Finnish population. Am J Clin Pathol 1982:77:665-73.
159. McAdam WA, Goligher JC. The occurrence of desmoid tumors in patients with familial polyposis coli. Br J Surg 1970:57:618-31.
160. Goellner JR, Soule EH. Desmoid tumors: an ultrastructural study of eight cases. Hum Pathol 1980:11:43-50.
161. Lynch HT. Fitzgibbons R Jr. Surgery, desmoid tumors, and familial adenomatous polyposis: case report and literature review. Am J Gastroenterol 1996:91:2598-601.
162. Lim CL, Walker MJ, Mehta RR, Das Gupta TK. Estrogen and antiestrogen binding sites in desmoid tumors. Eur J Cancer Clin Oncol 1986:22:583-7.
163. Dangel A, Meloni AM, Lynch HT, Sandberg AA. Deletion (5q) in a desmoid tumor of a patient with Gardner's syndrome. Cancer Genet Cytogenet 1994;78:94-8.
164. Okamoto M. Sato C, Kohno Y, et al. Molecular nature of chromosome 5q loss in colorectal tumors and desmoid tumors from patients with familial adenomatous polyposis. Hum Genet 1990:85:595-9.
165. Li M, Cordon-Cardo C, Gerald WL, Rosai J. Desmoid fibromatosds is a clonal process. Hum Pathol 1996:27:939-43.
166. Scales DK, Clark SK, Phillips RK, Venitt S. Lack of telomerase in desmoid tumors occurring sporadically and in association with familial adenomatous polyposis. Br J Surg 1998:85:965-9.
167. Brooks AP, Reznek RH, Nugent K, et al. CT appearances of desmcid tumours in familial adenomatous polyposis: further observations. Clin Radio! 1994:49:601-7.
168. Healy JC, Reznek RH, Clark SK, et al. MR appearances of desmoid tumors in familial adenomatous polyposis. AJR Am J Roentgenol 1997:169:465-72.
169. Kobayashi H. Sakahara H, Hosono M, et al. Soft-tissue tumors: diagnosis with Tc99m (V) dimercaptosuccinic acid scintigraphy. Radiology 1994:190:277-80.
170. Hardoff R, Ben Dov D, Front A. Gallium 67 scintigraphy in the evaluation of Gardner's syndrome. Cancer 1988;61:2353-8.
171. Tsukada K, Church JM, Jagelman DG, et al. Noncytotoxic drug therapy for intraabdominal desmoid tumor in patients with familial adenomatous polyposis. Dis Colon Rectum 1992;35:29-33.
172. Patel SR, Evans HL, Benjamin RS. Combination chemotherapy in adult desmoid tumors. Cancer 1993;72:3244-7.
173. Seiter K, Kemeny N. Successful treatment of a desmoid tumor with doxorubicin. Cancer 1993;71:2242-4.
174. Schnitzler M, Cohen Z, Blackstein M, et al. Chemotherapy for desmoid tumors in association with familial adenomatous polyposis. Dis Colon Rectum 1997;40: 798-801.
175. Tsukada K, Church JM, Jagelman DG, et al. Systemic cytotoxic chemotherapy and radiation therapy for desmoid in familial adenomatous polyposis. Dis Colon Rectum 1991;34:1090-2.
176. Oohata Y, Mibu R, Uehara S, et al. Regression of an aggressive abdominal desmoid tumor in a patient with familial adenomatous polyposis by hyperthermoradiotherapy. Am J Gastroenterol 1997;92:156-8.
177. Lynch HT, Smyrk T, Lanspa SJ, et al. Flat adenomas in a colon cancer-prone kindred. J Natl Cancer Inst 1988:80:278-82.
178. Wolber RA, Owen DA. Flat adenomas of the colon. Hum Pathol 1991 ;22:70-4.
179. Lynch HT, Smyrk TC, Lanspa SJ, et al. Upper gastrointestinal manifestations in families with hereditary flat adenoma syndrome. Cancer 1993:71:2709-14.
180. Crail HW. Multiple primary malignancies arising in the rectum, brain and thyroid: report of a case. US Nav Med Bull 1949;49:123-8.
181. Turcot J, Despres JP, St Pierre F. Malignant tumors of the central nervous system associated with familial polyposis of the colon: report of two cases. Dis Colon Rectum 1959;2:465-8.
182. Jarvis L, Bathurst N, Mohan D, Beckly D. Turcot's syndrome: a review. Dis Colon Rectum 1988:31:907-14.
183. Paraf F, Jothy S, Van Meir EG. Brain tumor-polyposis syndrome: Two genetic diseases? J Clin Oncol 1997:15:2744-58.
184. Kropilak M, Jagelman DG, Fazio VW, et al. Brain tumors in familial adenomatous polyposis. Dis Colon Rectum 1989;32:778-82.
185. Mori T, Nagase H, Horii A, et al. Germ-line and somatic mutations of the APC gene in patients with Turcot syndrome and analysis of APC mutations in brain tumors. Genes Chromosomes Cancer 1994;9:168-72.
186. Lynch HT, Smyrk TC, Watson P, et al. Genetics, natural history, tumor spectrum, and pathology of hereditary nonpolyposis colorectal cancer: an updated review. Gastroenterology 1993:104:1535-49.
187. Rutz HP, de Tribolet N, Calmes JM, Chapuis G. Long-time survival of a patient with glioblastoma and Turcot's syndrome. Case report. J Neurosurg 1991;74:813-5.
188. New strategies for treatment of hereditary colorectal cancer. Tokyo: Churchill Livingstone Japan; 1996.
189. Baba S. Hereditary nonpolyposis colorectal cancer: an update. Dis Colon Rectum 1997;40(suppl):S86-95.
190. Aarnio M, Mecklin JP, Aaltonen LA, et al. Life-time risk of different cancers in hereditary non-polyposis colorectal cancer (HNPCC) syndrome. Int J Cancer 1995;64:430-3.
191. Myrhoj T, Bisgaard ML, Bernstein I, et al. Hereditary non-polyposis colorectal cancer: clinical features and survival: results from the Danish HNPCC register. Scand J Gastroenterol 1997;32:572-6.
192. Watson P, Lynch HT. Extracolonic cancer in hereditary nonpolyposis colorectal cancer. Cancer 1993;71:677-85.
193. Warthin AS. Heredity with reference to carcinoma. Arch Intern Med 1913;12:546-55.
194. Lynch HT, Shaw MW, Magnuson CW, et al. Hereditary factors in cancer: study of two large midwestern kindred. Arch Intern Med 1966;! 17:206-12.
195. Boland CR, Troncale FJ. Familial colonie cancer without antecedent polyposis. Ann Intern Med 1984; 100:700-1.
196. Mecklin JP. Frequency of hereditary colorectal carcinoma. Gastroenterology 1987;93:1021-5.
197. Vasen HF, den Hartog Jager PC, Menko FH, Nagengast FM. Screening for hereditary non-polyposis colorectal cancer: a study of 22 kindred in The Netherlands. Am JMed 1989;86:278-81.
198. Vasen HF, Mecklin JP, Khan PM, Lynch HT. The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC). Dis Colon Rectum 1991:34:424-5.
199. Mecklin JP, Sipponen P, Jarvinen HJ. Histopathology of colorectal cîtrcinomas and adenomas in cancer family syndrome. Dis Colon Rectum 1986;29:849-53.
200. Jass JR, Stewart SM, Stewart J, Lane MR. Hereditary nonpolyposis colorectal cancer: morphologies, genes and mutations. Mutât Res 1994;310:125-32i.
201. Jass JR. Colorectal adenomas in surgical specimens from subjects with hereditary non-polyposis colorectal cancer. Histopathology 1995;27:263-7.
202. Jass JR, Smyrk TC, Stewart SM, et al. Pathology of hereditary non-polyposis colorectal cancer. Anticancer Res 1994;14:1631-4.
203. Sankila R, Aaltonen LA, Jarvinen HJ, Mecklin JP. Better survival rates in patients with MLH1 -associated hereditary colorectal cancer. Gastroenterology 1996; 110:682-7.
204. Rodriguez-Bigas MA, Boland CR, Hamilton SR, et al. A National Gincer Institute Workshop on hereditary nonpolyposis colorectal cancer syndrome: meeting highlights and Bethesda guidelines. J Natl Cancer Inst 1997:89:1758-62.
205. Aaltonen LA, Peltomaki P, Leach FS, et al. Clues to the pathogenesis of familial colorectal cancer. Science 1993;260:812-6.
206. Peltomaki P, de la Chapelle A. Mutations predisposing to hereditary nonpolyposis colorectal cancer. Adv Cancer Res 1997;71:93-119.
207. Leach FS, Nicolaides NC, Papadopoulos N, et al. Mutations of a mu:S homolog in hereditary nonpolyposis colorectal cancer. Cell 1993;75:1215-25.
208. Fishel R, Lescoe MK, Rao MR, et al. The human imitator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer [published erratum appears in Cell 1994 8;77:167]. Cell 1993;75:1027-38.
209. Papadopoulos N, Nicolaides NC, Wei YF, et al. Mutation of a mutL homolog in hereditary colon cancer. Science 1994;263:1625-9.
210. Nicolaides NC, Papadopoulos N, Liu B, et al. Mutations of two PMS homologues in hereditary nonpolyposis colon cancer. Nature 1994;371:75-80.
211. Peltomaki P, Vasen HF. Mutations predisposing to hereditary nonpolyposis colorée-tal cancer: database and results of a collaborative study: the International Collaborative Group on hereditary nonpolyposis colorectal cancer. Gastroenterology 1997; 113:1146-58.
212. Drummond JT, Li GM, Longley MJ, Modrich P. Isolation of an hMSH2-p!60 heterodimer that restores DNA mismatch repair to tumor cells. Science 1995;268: 1909-12.
213. Palombo F, Gallinari P, laccarino I, et al. GTBP, a 160-kilodalton protein essential for mismatch-binding activity in human cells. Science 1995:268:1912-4.
214. Watanabe A, Ikejima M, Suzuki N, Shimada T. Genomic organization and expression of the human MSH3 gene. Genomics 1996:31:311-8.
215. AkiyamaY, Tsubouchi N, YuasaY. Frequent somatic mutations of hMSH3 with reference to microsatellite instability in hereditary nonpolyposis colorectal cancers. Biochem Biophys Res Commun 1997;236:248-52.
216. AkiyamaY, Sato H, Yamada T, et al. Germ-line mutation of the hMSH6/GTBP gene in an atypical hereditary nonpolyposis colorectal cancer kindred. Cancer Res 1997;57:3920-3.
217. Wijnen J, Vasen H, Khan PM, et al. Seven new mutations in hMSH2, an HNPCC gene, identified by denaturing gradient-gel electrophoresis. Am J Hum Genet 1995;56:1060-6.
218. Nystrom-Lahti M, Wu Y, Moisio AL, et al. DNA mismatch repair gene mutations in 55 kindred with verified or putative hereditary non-polyposis colorectal cancer. Hum Mol Genet 1996;5:763-9.
219. Nystrom-Lahti M, Sistonen P, Mecklin JP, et al. Close linkage to chromosome 3p and conservation of ancestral founding haplotype in hereditary nonpolyposis colorectal cancer families. Proc Natl Acad Sei U S A 1994;91:6054-8.
220. Vasen HF, Nagengast FM, Khan PM. Interval cancers in hereditary non-polyposis colorectal cancer (Lynch syndrome) [letter]. Lancet 1995;345:1183-4.
221. Giardiello FM. Genetic testing in hereditary colorectal cancer [clinical conference]. JAMA 1997;278:1278-81.
222. Dunlop MG, Farrington SM, Carothers AD, et al. Cancer risk associated with germline DNA mismatch repair gene mutations. Hum Mol Genet 1997;6:105-10.
223. Pensotti V, Radiée P, Presciuttini S, et al. Mean age of tumor onset in hereditary nonpolyposis colorectal cancer (HNPCC) families correlates with the presence of mutations in DNA mismatch repair genes. Genes Chromosomes Cancer 1997;19:135-42.
224. Weber TK, Conlon W, Petrelli NJ, et al. Genomic DNA-based hMSH2 and hMLH 1 mutation screening in 32 Eastern United States hereditary nonpolyposis colorectal cancer pedigrees. Cancer Res 1997:57:3798-803.
225. lonov Y, Peinado MA, Malkhosyan S, et al. Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonie carcinogenesis. Nature 1993:363:558-61.
226. Peltomaki P, Aaltonen LA, Sistonen P, et al. Genetic mapping of a locus predisposing to human colorectal cancer. Science 1993:260:810-2.
227. Perucho M. Cancer of the microsatellite mutator phenotype. Biol Chem 1996;377:675-84.
228. Dietmaier W, Wallinger S, Bocker T, et al. Diagnostic microsatellite instability: definition and correlation with mismatch repair protein expression. Cancer Res 1997:57:4749-56.
229. Markowitz S, Wang J, Myeroff L, et al. Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability. Science 1995;268:1336-8.
230. Souza RF, Appel R, Yin J, et al. Microsatellite instability in the insulin-like growth factor II receptor gene in gastrointestinal tumours (published erratum appears in Nat Genet 1996;14:488) [letter]. Nat Genet 1996:14:255-7.
231. Rampino N, Yamamoto H, lonov Y, et al. Somatic frameshift mutations in the BAX gene in colon cancers of the microsatellite mutator phenotype. Science 1997;275: 967-9.
232. Branch P, Bicknell DC, Rowan A, et al. Immune surveillance in colorectal carcinoma [letter). Nat Genet 1995;9:231-2.
233. Aaltonen LA, Peltomaki P, Mecklin JP, et al. Replication errors i.i benign and malignant tumors from hereditary nonpolyposis colorectal cancer pa.ients. Cancer Res 1994:54:1645-8.
234. Thibodeau SN. French AJ, Cunningham JM, et al. Microsatellite instability in colorectal cancer: different mutator phenotypes and the principal involvement of hMLHl. Cancer Res 1998:58:1713-8.
235. Liu B. Nicolaides NC, Markowitz S, et al. Mismatch repair gene defects in sporadic colorectal cancers with microsatellite instability. Nat Genet 1995:9:43-55.
236. Aaltonen LA, Salovaara R, Kristo P, et al. Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease. N Engl J Med 1998:338:1481-7.
237. Forster S, Sattler HP, Hack M, et al. Microsatellite instability in sporadic carcinomas of the proximal colon: association with diploid DNA content, negative protein expression of p53, and distinct histomorphologic features. Surgery 1998:123:13-8.
238. Thibodeau SN, Bren G, Schaid D. Microsatellite instability in cancel' of the proximal colon. Science 1993:260:816-9.
239. Lothe RA, Peltomaki P, Meling GI, et al. Genomic instability in cole rectal cancer: relationship to clinicopathological variables and family history. Cancer Res 1993:53:5849-52.
240. Akiyama Y, Iwanaga R, Saitoh K, et al. Transforming growth factor beta type II receptor gene mutations in adenomas from hereditary nonpolyposis colorectal cancer. Gastroenterology 1997:112:33-9.
241. Vasen HF. Wijnen JT, Menko FH, et al. Cancer risk in families with hereditary nonpolyposis colorectal cancer diagnosed by mutation analysis (published erratum appears in Gastroenterology 1996:111:1402). Gastroenterology 1996:110:1020-7.
242. Lin KM, Shashidharan M, Thorson AG, et al. Cumulative incidence of colorectal and extracolonic cancers in MLH1 and MSH2 mutation carriers of hereditary nonpolyposis colorectal cancer. J Gastrointest Surg 1998:2:67-71.
243. Jager AC, Bisgaard ML, Myrhoj T, et al. Reduced frequency of extracolonic cancers in hereditary nonpolyposis colorectal cancer families with monoallelic hMLH 1 expression. Am J Hum Genet 1997:61:129-38.
244. Guillem JG, Bastar AL, Ng J, et al. Clustering of colorectal cancer in families of probands under 40 years of age. Dis Colon Rectum 1996:39:1004-7.
245. Hall NR, Finan PJ, Ward B, et al. Genetic susceptibility to colorectal cancer in patients under 45 years of age. Br J Surg 1994;81:1485-9.
246. Fante R, Benatti P, di Gregorio C, et al. Colorectal carcinoma in different age groups: a population-based investigation. Am J Gastroenterol 1997:92:1505-9.
247. Evans DG. Walsh S, Jeacock J, et al. Incidence of hereditary non-polyposis col-orectal cancer in a population- based study of 1137 consecutive cases of colorectal cancer. Br J Surg 1997;84:1281-5.
248. Han HJ, Yuan Y, Ku JL, et al. Germline mutations of hMLHl and hMSH2 genes in Korean hereditary nonpolyposis colorectal cancer. J Natl Cancer Inst 1996;88:1317-9.
249. Landis SH, Murray T, Bolden S, Wingo PA. Cancer statistics, 1998 (published erratum appears in CA Cancer J Clin 1998;48:192). CA Cancer J Clin 1998;48:6-29.
250. Ponz de Leon M, Sassatelli R, Benatti P, Roncucci L. Identification of hereditary nonpolyposis colorectal cancer in the general population: the 6-year experience of a population-based registry. Cancer 1993;71:3493-501.
251. Kee F, Collins B J. How prevalent is cancer family syndrome? Gut 1991 ;32:509-12.
252. Westlake PJ, Bryant HE, Huchcroft SA, Sutherland LR. Frequency of hereditary nonpolyposis colorectal cancer in southern Alberta. Dig Dis Sei 1991;36:1441-7.
253. Mecklin JP, Jarvinen HJ, Hakkiluoto A, et al. Frequency of hereditary nonpolyposis colorectal cancer: a prospective multicenter study in Finland. Dis Colon Rectum 1995;38:588-93.
254. Muto T, Bussey HJ, Morson BC. The evolution of cancer of the colon and rectum. Cancer 1975;36:2251-70.
255. Burke W, Petersen G, Lynch P, et al. Recommendations for follow-up care of individuals with an inherited predisposition to cancer. I. Hereditary nonpolyposis colon cancer: Cancer Genetics Studies Consortium. JAMA 1997;277:915-9.
256. Jarvinen HJ, Mecklin JP, Sistonen P. Screening reduces colorectal cancer rate in families with hereditary nonpolyposis colorectal cancer. Gastroenterology 1995;108:1405-11.
257. Byers T, Levin B, Rothenberger D, et al. American Cancer Society guidelines for screening and surveillance for early detection of colorectal polyps and cancer: update 1997: American Cancer Society Detection and Treatment Advisory Group on Colorectal Cancer. CA Cancer J Clin 1997;47:154-60.
258. Winawer SJ, Reicher RH, Miller L, et al. Colorectal cancer screening: clinical guidelines and rationale (published errata appear in Gastroenterology 1997:112:1060 & 1998; 114:625). Gastroenterology 1997;! 12:594-642.
259. Guillem JG, Puig-La Calle J, Cellini C, et al. Varying features of early age-of-onset hereditary nonpolyposis colorectal cancer (HNPCC) and non-HNPCC patients. Dis Colon Rectum 1998.
260. Rodriguez-Bigas MA, Vasen HF, Pekka-Mecklin J, et al. Rectal cancer risk in hereditary nonpolyposis colorectal cancer after abdominal colectomy: International Collaborative Group on HNPCC. Ann Surg 1997;225:202-7.
261. Lynch HT. Is there a role for prophylactic subtotal colectomy among hereditary nonpolyposis colorectal cancer germline mutation carriers? [editorial]. Dis Colon Rectum 1996;39:109-10.
262. Rossi SC, Srivastava S. National Cancer Institute Workshop on Genetic Screening for Colorectal Cancer. J Natl Cancer Inst 1996:88:331-9.
263. Menko FH, Wijnen JT, Khan PM, et al. Genetic counseling in hereditary nonpolyposis colorectal cancer. Oncology (Huntingt) 1996;10:71-6; discussion 81-2.
264. Wijnen JT, Vasen HF, Khan PM, et al. Clinical findings with implications for genetic testing in families with clustering of colorectal cancer. N Engl J Med 1998;339:511-8.
265. Lynch HT, Lemon SJ, Karr B, et al. Etiology, natural history, management and mol-ecular genetics of hereditary nonpolyposis colorectal cancer (Lynch syndromes): genetic counseling implications. Cancer Epidemiol Biomarkers Prev 1997;6:987-91.
266. Guillem JG. Molecular diagnosis of hereditary nonpolyposis colon cancer [letter]. N Engl J Med 1998;339:924-5.
267. Schwartz RA, Torre DP. The Muir-Torre syndrome: a 25-year retrospect. J Am AcadDermatol 1995;33:90-104.
268. Hailing KC, Honchel R, Pittelkow MR, Thibodeau SN. Microsatellite instability in keratoacanthoma. Cancer 1995;76:1765-71.
269. Fusaro RM, Lemon SJ, Lynch HT. Muir-Torre syndrome and defective DNA mismatch repair genes [letter; comment]. J Am Acad Dermatol 1996;35:493-4.
270. Honchel R, Hailing KC, Schaid DJ, et al. Microsatellite instability in Muir-Torre syndrome. Cancer Res 1994;54:1159-63.
271. Hall NR, Murday VA, Chapman P, et al. Genetic linkage in Muir-Torre syndrome to the same chromosomal region as cancer family syndrome. liur J Cancer 1994;2:180-2.
272. Kolodner RD, Hall NR, Lipford J, et al. Structure of the human MSH2 locus and analysis of two Muir-Torre kindred for msh2 mutations (published erratum appears in Genomics 1995 10;28:613). Genomics 1994;24:516-26.
273. Kruse R, Lamberti C, Wang Y, et al. Is the mismatch repair deficient type of MuirTorre syndrome confined to mutations in the hMSH2 gene? Hum Genet 1996;98:747-50.
274. Bapat B, Xia L, Madlensky L, et al. The genetic basis of Muir-Torre syndrome includes the hMLHl locus [letter]. Am J Hum Genet 1996;59:736-9.
275. Desai DC, Neale KF, Talbot IC, et al. Juvenile polyposis. Br J Surg 1995;82:14-7.
276. Coburn MC, Pricolo VE, DeLuca FG, Bland KI. Malignant potentiel in intestinal juvenile polyposis syndromes. Ann Surg Oncol 1995;2:386-91.
277. Haggitt RC, Reid BJ. Hereditary gastrointestinal polyposis syndromes. Am J Surg Pathol 1986;10:871-87.
278. Sachatello CR, Griffen WO Jr. Hereditary polypoid diseases of the gastrointestinal tract: a working classification. Am J Surg 1975;129:198-203.
279. Dean PA. Hereditary intestinal polyposis syndromes. Rev Gastroenterol Mex 1996;61:100-11.
280. Sachatello CR, Hahn IS, Carrington CB. Juvenile gastrointestinal polyposis in a female infant: report of a case and review of the literature of a recently recognized syndrome. Surgery 1974;75:107-14.
281. Jass JR, Williams CB, Bussey HJ, Morson BC. Juvenile polyposis: a precancerous condition. Histopathology 1988;13:619-30.
282. Goodman ZD, Yardley JH, Milligan FD. Pathogenesis of colonie polyps in multiple juvenile polyposis: report of a case associated with gastric polyps and carcinoma of the rectum. Cancer 1979;43:1906-13.
283. O'Riordain DS, O'Dwyer PJ, Cullen AF, et al. Familial juvenile polyposis coli and colorectal cancer. Cancer 1991;68:889-92.
284. Giardiello FM, Offerhaus JG. Phenotype and cancer risk of various polyposis syndromes. Eur J Cancer 1995;31 A: 1085-7.
285. Olschwang S, Serova-Sinilnikova OM, Lenoir GM, Thomas G. PTEN germ-line mutations in juvenile polyposis coli [letter]. Nat Genet 1998;18:12-4.
286. Li J, Yen C, Liaw D, et al. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 1997;275:1943-7.
287. Steck PA, Pershouse MA, Jasser SA, et al. Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat Genet 1997; 15:356-62.
288. Risinger JI, Hayes AK, Berchuck A, Barrett JC. PTEN/MMAC1 mutations in endometrial cancers. Cancer Res 1997;57:4736-8.
289. Jacoby RF, Schlack S, Cole CE, et al. A juvenile polyposis tumor suppressor locus at 10q22 is deleted from nonepithelial cells in the lamina propria. Gastroenterology 1997;! 12:1398-403.
290. Marsh DJ, Roth S, Lunetta KL, et al. Exclusion of PTEN and 10q22-24 as the susceptibility locus for juvenile polyposis syndrome. Cancer Res 1997:57:5017-21.
291. Howe JR, Roth S, Ringold JC, et al. Mutations in the SMAD4/DPC4 gene in juvenile polyposis. Science 1998;280:1086-8.
292. Kinzler KW, Vogelstein B. Landscaping the cancer terrain [comment]. Science 1998;280:1036-7.
293. Reference deleted in press.
294. Subramony C, Scott-Conner CE, Skelton D, Hall TJ. Familial juvenile polyposis: study of a kindred: evolution of polyps and relationship to gastrointestinal carcinoma. Am J Clin Pathol 1994; 102:91-7.
295. Sassatelli R, Bertoni G, Serra L, et al. Generalized juvenile polyposis with mixed pattern and gastric cancer. Gastroenterology 1993;104:910-5.
296. Watanabe A, Nagashima H, Motoi M, Ogawa K. Familial juvenile polyposis of the stomach. Gastroenterology 1979;77:148-51.
297. Scott-Conner CE, Hausmann M, Hall TJ, et al. Familial juvénile polyposis: patterns of recurrence and implications for surgical management. J Am Coll Surg 1995;181:407-I3.
298. Stoltenberg RL, Madsen JA, Schlack SC, et al. Neoplasia in ileal pouch mucosa after total proctocolectomy for juvenile polyposis: report of a case. Dis Colon Rectum 1997:40:726-30.
299. Herrera L, Obrador A. Hereditary polyposis syndromes. In: Cohen AM, Winawer SJ, Friedman MA, Gunderson LL, editors. Cancer of colon, rectum, and anus. New York: McGraw-Hill, Inc; 1995. p. 83-104.
300. Jeghers H, McKusick VA, Katz KH. Generalized intestinal polyposis and melanin spots of the oral mucosa, lips and digits: a syndrome of diagnostic significance. N Engl J Med 1949:241:992-1005.
301. Spigelman AD, Arese P, Phillips RK. Polyposis: the Peutz-Jeghers syndrome. Br J Surg 1995;82:1311-4.
302. Reid JD. Intestinal carcinoma in the Peutz-Jeghers syndrome. JAMA 1974;229:833-4.
303. Hizawa K, lida M, Matsumoto T, et al. Neoplastic transformation arising in PeutzJeghers polyposis. Dis Colon Rectum 1993;36:953-7.
304. Giardiello FM, Welsh SB, Hamilton SR, et al. Increased risk of cancer in the PeutzJeghers syndrome. N Engl J Med 1987;316:1511-4.
305. Hemminki A, Tomlinson I, Markie D, et al. Localization of a susceptibility locus for Peutz-Jeghers syndrome to 19p using comparative genomic hybridization and targeted linkage analysis. Nat Genet 1997;15:87-90.
306. Jenne DE, Reimann H, Nezu J, et al. Peutz-Jeghers syndrome is caused by mutations in a novel serine threonine kinase. Nat Genet 1998;18:38-43.
307. Tomlinson IP, Houlston RS. Peutz-Jeghers syndrome. J Med Genet 1997;34: 1007-11.
308. Foster DR, Foster DB. Gall-bladder polyps in Peutz-Jeghers syndrome. Postgrad MedJ 1980;56:373-6.
309. Westerman AM, van Velthuysen ML, Bac DJ, et al. Malignancy in Peutz-Jeghers syndrome? The pitfall of pseudo-invasion. J Clin Gastroenterol 1997;25:387-90.
310. Hood AB, Krush AJ. Clinical and dermatologie aspects of the hereditary intestinal polyposes. Dis Colon Rectum 1983;26:546-8.
311. Hizawa K, lida M, Matsumoto T, et al. Cancer in Peutz-Jeghers syndrome. Cancer 1993:72:2777-81.
312. Yamamoto M, Hoshino H, Onizuka T, et al. Thyroid papillary adenocarcinoma in a woman with Peutz-Jeghers syndrome. Intern Med 1992;31:1117-9.
313. Niewenhuis JC, Wolf MC, Kass EJ. Bilateral asynchronous Sertoli c;ll tumor in a boy with the Peutz-Jeghers syndrome. J Urol 1994; 152:1246-8.
314. Konishi F, Wyse NE, Muto T, et al. Peutz-Jeghers polyposis associated with carcinoma of the digestive organs: report of three cases and review of the literature. Dis Colon Rectum 1987:30:790-9.
315. Dozois RR, Kempers RD, Dahlin DC, Bartholomeew LG. Ovarian tumors associated with the Peutz-Jeghers syndrome. Ann Surg 1970; 172:233-8.
316. Riley E, Swift M. A family with Peutz-Jeghers syndrome and bilateral breast cancer. Cancer 1980;46:815-7.
317. Davies GR, Benson MJ, Gertner DJ, et al. Diagnostic and therapeutic push type enteroscopy in clinical use. Gut 1995:37:346-52.
318. Rossini FP, Pennazio M. Enteroscopy and Peutz Jeghers syndrome [letter; comment]. Am J Gastroenterol 1996:91:2252-3.
319. Spigelman AD, Murday V, Phillips RK. Cancer and the Peutz-Jeghers syndrome. Gut 1989:30:1588-90.
320. Albrecht S, Haber RM, Goodman JC, Duvic M. Cowden syndrome and LhermitteDuclos disease. Cancer 1992;70:869-76.
321. Nelen MR, Padberg GW, Peelers EA, et al. Localization of the gens for Cowden disease to chromosome 10q22-23. Nat Genet 1996; 13:114-6.
322. Nelen MR, van Staveren WC, Peelers EA, et al. Germline mulations in the PTEN/MMAC1 gene in patients with Cowden disease. Hum Mol Genet 1997; 6:1383-7.
323. Liaw D, Marsh DJ, Li J, et al. Germline mutations of the PTEN geie in Cowden disease, an inherited breast and thyroid cancer syndrome. Nat Genet 1997;16:64-7.
324. Eng C, Murday V, Seal S, et al. Cowden syndrome and Lhermitte-Duclos disease in a family: a single genetic syndrome with pleiotropy? J Med Genet 1994;31:458-61.
325. Rhei E, Kang L, Bogomolniy F, et al. Mutation analysis of the putative tumor suppressor gene PTEN/MMAC1 in primary breast carcinomas. Cancer Res 1997; 57:3657-9.
326. Dahia PL, Marsh DJ, Zheng Z, et al. Somatic deletions and mutations ;n the Cowden disease gene, PTEN, in sporadic thyroid tumors. Cancer Res 1997;57:4710-3.
327. Finan MC, Ray MK. Gastrointestinal polyposis syndromes. Dermatol Clin 1989;7:419-34.
328. Carlson GJ, Nivatvongs S, Snover DC. Colorectal polyps in Cowden's disease (multiple hamartoma syndrome). Am J Surg Pathol 1984;8:763-70.
329. Daniel ES, Ludwig SL, Lewin KJ, et al. The Cronkhite-Canada Syndrome: an analysis of clinical and pathologic features and therapy in 55 patients. Medicine (Baltimore) 1982;61:293-309.
330. Misra SP, Misra V, Dwivedi M, et al. Cronkhite-Canada syndrome without colonie polyps. Endoscopy 1997;29:333.
331. Shekitka KM, Sobin LH. Ganglioneuromas of the gastrointestinal tract: relation to Von Recklinghausen disease and other multiple tumor syndromes. Am J Surg Pathol 1994;18:250-7.
332. 33la. DeSchryver-Kecksmeti K, Clouse RE, Goldstein MN, Gerseil D, O'Neal L. Intestinal ganglioneuromatosis: a manifestation of overproduction of nerve growth factor? N Engl J Med 1983;308:635-9.
333. Mendelsohn G, Diamond MP. Familial ganglioneuromatous polyposis of the large bowel: report of a family with associated juvenile polyposis. Am J Surg Pathol 1984;8:515-20.
334. Weidner N, Flanders DJ, Mitros FA. Mucosal ganglioneuromatosis associated with multiple colonie polyps. Am J Surg Pathol 1984;8:779-86.
335. Ruvalcaba RH, Myhre S, Smith DW. Sotos syndrome with intestinal polyposis and pigmentary changes of the genitalia. Clin Genet 1980:18:413-6.
336. Foster MA, Kilcoyne RF. Ruvalcaba-Myhre-Smith syndrome: a new consideration in the differential diagnosis of intestinal polyposis. Gastrointest Radiol 1986; 11:349-50.
337. DiLiberti JH, Weleber RG, Budden S. Ruvalcaba-Myhre-Smith syndrome: a case with probable autosomal-dominant inheritance and additional manifestations. Am J Med Genet 1983;15:491-5.
338. Marsh DJ, Dahia PL, Zheng Z, et al. Germline mutations in PTEN are present in Bannayan-Zonana syndrome [letter]. Nat Genet 1997;16:333-4.
339. Castro EB, Stearns MW. Lipoma of the large intestine: a review of 45 cases. Dis Colon Rectum 1972; 15:441-4.
340. Taylor BA, Wolff BG. Colonie lipomas: report of two unusual cases and review of the Mayo Clinic experience, 1976-1985. Dis Colon Rectum 1987;30:888-93.
341. Ryan J, Martin JE, Pollock DJ. Fatty tumours of the large intestine: a clinicopathological review of 13 cases. Br J Surg 1989;76:793-6.
342. Ramirez JM, Ortego J, Deus J, et al. Lipomatous polyposis of the colon. Br J Surg 1993:80:349-50.
343. Kelly JK, Langevin JM, Price LM, et al. Giant and symptomatic inflammatory polyps of the colon in idiopathic inflammatory bowel disease. Am J Surg Pathol 1986:10:420-8.
344. Kelly JK, Gabos S. The pathogenesis of inflammatory polyps. Dis Colon Rectum 1987:30:251-4.
345. Koga H, lida M, Aoyagi K, et al. Generalized giant inflammatory polyposis in a patient with ulcerative colitis presenting with protein-losing enteropathy. Am J Gastroenterol 1995:90:829-31.
346. Fenoglio CM, Pascal RR. Colorectal adenomas and cancer: pathologic relationships. Cancer 1982;50(suppl):2601-8.
347. Jorgensen H, Mogensen AM, Svendsen LB. Hyperplastic polyposis of the large bowel: three cases and a review of the literature. Scand J Gastroenterol 1996:31:825-30.
348. Estrada RG, Spjut HJ. Hyperplastic polyps of the large bowel. Am J Surg Pathol 1980;4:127-33.
349. Jass JR. Relation between metaplastic polyp and carcinoma of the colorectum. Lancet 1983:1:28-30.
350. Whitelaw SC, Murday VA, Tomlinson IP, et al. Clinical and molecular features of the hereditary mixed polyposis syndrome. Gastroenterology 1997; 112:327-34.
351. Thomas HJ, Whitelaw SC, Cottrell SE, et al. Genetic mapping of hereditary mixed polyposis syndrome to chromosome 6q. Am J Hum Genet 1996;58:770-6.
352. Giardiello FM, Hamilton SR. Hereditary mixed polyposis syndrome: a zebra or a horse dressed in pinstripes [editorial; comment]. Gastroenterology 1997;! 12:643-5.
353. Bulow S, Bulow C, Nielsen TF, et al. Centralized registration, prophylactic examination, and treatment results in improved prognosis in familial adenomatous polyposis: results from the Danish Polyposis Register. Scand J Gastroenterol 1995;30:989-93.
354. Rodriguez-Bigas MA, Lee PH, O'Malley L, et al. Establishment or a hereditary nonpolyposis colorectal cancer registry. Dis Colon Rectum 1996;39:(>49-53.
355. Macrae FA, St John DJ, Muir EP, et al. Impact of a hospital-based register on the management of familial adenomatous polyposis. Med J Aust 1989;151:552-7.